Entera Bio Ltd. (ENTX) stock
ENTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$3.11−0.11 (-3.42%)
Close on Nov 13, 2026Market cap $538.47MP/E –Yield –
Entera Bio enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Entera Bio's enterprise value was $147.41M on Nov 11, 2026, against $100.11M a year earlier. Over the last 5 years it ranged from $5.23M to $147.41M, with a median of $52.70M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $147.41M | +84.2% |
| 2025 | Dec 31, 2025 | $80.02M | +13.5% |
| 2024 | Dec 31, 2024 | $70.49M | +626.5% |
| 2023 | Dec 29, 2023 | $9.70M | +44.6% |
| 2022 | Dec 30, 2022 | $6.71M | -87.3% |
| 2021 | Dec 31, 2021 | $52.70M | +430.9% |
| 2020 | Dec 31, 2020 | $9.93M | -41.7% |
| 2019 | Dec 31, 2019 | $17.02M | +191.2% |
| 2018 | Dec 31, 2018 | $5.84M | – |
See a number that looks wrong?